CVA Family Office’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-100
| Closed | -$11K | – | 932 |
|
|
2021
Q3 | $11K | Sell |
100
-145
| -59% | -$16K | 0.01% | 293 |
|
|
2021
Q2 | $45K | Buy |
245
+5
| +2% | +$918 | 0.01% | 382 |
|
|
2021
Q1 | $37K | Buy |
240
+140
| +140% | +$21.6K | 0.01% | 311 |
|
|
2020
Q4 | $16K | Hold |
100
| – | – | 0.01% | 280 |
|
|
2020
Q3 | $11K | Hold |
100
| – | – | 0.01% | 293 |
|
|
2020
Q2 | $11K | Hold |
100
| – | – | 0.01% | 257 |
|
|
2020
Q1 | $9K | Buy |
+100
| New | +$9K | 0.01% | 246 |
|